Role of Brain Injury Biomarkers in Predicting Clinical Severity and Mortality of Anti-IgLON5 Disease (S38.003)
To assess NfL and GFAP as biomarkers of disease severity and mortality in anti-IgLON5 disease.
Authors
- Antonio Farina (ORCID: https://orcid.org/0000-0002-5551-0185)
- Sophie Trouillet‐Assant (ORCID: https://orcid.org/0000-0001-6439-4705)
- Macarena Villagrán‐García (ORCID: https://orcid.org/0000-0001-9236-2428)
- Jérôme Honnorat (ORCID: https://orcid.org/0000-0002-4721-5952)
- Bastien Joubert (ORCID: https://orcid.org/0000-0003-4631-3056)
- Amna Abichou-Klich
- Anne‐Laurie Pinto (ORCID: https://orcid.org/0009-0004-5127-3137)
Institutions
- Hospices Civils de Lyon (FR)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211780
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00